Short answer · Medically reviewed summary · Last updated: 2026-04-06
Hashimoto’s disease, also known as chronic lymphocytic thyroiditis, is a common autoimmune condition with an estimated prevalence of approximately 1% to 5% in the general population, though exact figures vary significantly due to widespread underdiagnosis. Epidemiological Overview While Hashimoto’s disease is highly prevalent, it is not classified as a rare disease by typical clinical standards. The incidence rate is estimated at approximately 0.3 to 1.5 cases per 1,000 individuals annually.
1 people with Hashimotos Disease have shared their first-person experience on this question at DiseaseMaps.
What is the prevalence of Hashimotos Disease?
Prevalence of Hashimotos Disease: how many people are affected worldwide, differences by sex and region, with sources.
Hashimoto’s disease, also known as chronic lymphocytic thyroiditis, is a common autoimmune condition with an estimated prevalence of approximately 1% to 5% in the general population, though exact figures vary significantly due to widespread underdiagnosis.
Epidemiological Overview
While Hashimoto’s disease is highly prevalent, it is not classified as a rare disease by typical clinical standards. The incidence rate is estimated at approximately 0.3 to 1.5 cases per 1,000 individuals annually. The condition exhibits a strong gender disparity, affecting females significantly more often than males, with a ratio ranging from 7:1 to 10:1. While Hashimoto’s disease can occur at any age, it is most frequently diagnosed in adults between the ages of 30 and 50, though pediatric cases are increasingly recognized.
Variations and Challenges
Geographic and ethnic variations in the prevalence of Hashimoto’s disease have been observed, often linked to iodine intake levels and genetic susceptibility factors. However, obtaining precise global statistics remains difficult. Many individuals remain undiagnosed for years because early-stage Hashimoto’s disease often presents with subtle or non-specific symptoms that mimic other conditions, leading to significant delays in clinical identification. Consequently, official health statistics likely underestimate the true burden of the disease.
Community Insights
At DiseaseMaps.org, we have seen 1,812 people with Hashimoto’s disease join our community to share their personal health journeys. This real-world patient data provides a vital, complementary perspective to clinical literature, highlighting the diverse ways this condition impacts daily life beyond what is captured in traditional epidemiological surveys. By mapping these experiences, we gain a clearer picture of the diagnostic hurdles and the long-term management challenges faced by those living with Hashimoto’s disease.
Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: The portal for rare diseases and orphan drugs
- American Thyroid Association (ATA)
Posted Oct 1, 2017 by Carolina_Tia 2050
